Microdosing Psychedelics: Does it Work?
In spite of the hype, a new Imperial College study says the jury is still out.
Mental Health - Page 13
Psilocybin Mushroom Extract More Effective Than Pure Psilocybin in Reducing OCD Symptoms in Mice
This study provides more evidence for the entourage effect in magic mushrooms.
Positive Effects of Psilocybin Truffles Last For Seven Days, Study Finds
Enhancement of empathy, creative thinking, and subjective well-being outlasts the intoxication.
Single Inhalation of Dried Toad Secretions Provides Sub-Acute and Sustained Benefits
Increased mindfulness and decreased anxiety, depression, and stress were seen right away, becoming more significant four weeks after dosing.
The Importance of Set and Setting in Psychedelic Therapy
The context of the psychedelic experience plays a critical role in determining positive outcomes for patients.
Is Esketamine the First FDA-Approved Psychedelic Drug?
The answer is yes and no. It's a matter of perspective.
Studies Find 5-MeO-DMT Improves Symptoms of Anxiety and Depression
Improvements in depression and anxiety are associated with greater intensity of mystical experiences and higher ratings of the spiritual significance and personal meaning.
TheraPsil Seeks Permission From Health Canada to Use Psilocybin Treatments for Dying Patients
Bruce Tobin is asking Health Canada to approve psilocybin to treat anxiety and depression in end-of-life patients.
Analysis of the Future Psilocybin Pharmaceutical Market
FDA approval for psilocybin-assisted therapy for depression appears to be on the horizon.
Johns Hopkins Researchers Call for Rescheduling Psilocybin
Researchers push to move psilocybin from Schedule I to Schedule IV if Phase III clinical trials are successful.